Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4499 USD | +3.50% | -56.32% | -39.21% |
Mar. 26 | Wall Street Set to Open Modestly Higher Tuesday Ahead Consumer Confidence Reading | MT |
Mar. 26 | US Futures Trend Higher Ahead of Durable Goods, House Prices, Consumer Confidence Readings | MT |
Financials (USD)
Sales 2023 * | - | Sales 2024 * | - | Capitalization | 1.69M |
---|---|---|---|---|---|
Net income 2023 * | -12M | Net income 2024 * | - | EV / Sales 2023 * | - |
Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-0.06
x | P/E ratio 2024 * |
-
| Employees | 37 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 86.56% |
Latest transcript on NeuBase Therapeutics, Inc.
1 day | +3.50% | ||
1 week | -56.32% | ||
Current month | -47.69% | ||
1 month | -48.59% | ||
3 months | -36.72% | ||
6 months | -52.14% | ||
Current year | -39.21% |
Managers | Title | Age | Since |
---|---|---|---|
Todd Branning
CEO | Chief Executive Officer | 54 | 22-01-09 |
Dani Stoltzfus
PRN | Corporate Officer/Principal | - | - |
Ron Sarkar
PRN | Corporate Officer/Principal | - | 21-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dov Goldstein
CHM | Chairman | 56 | 19-07-11 |
Eric Richman
BRD | Director/Board Member | 63 | 19-07-11 |
Director/Board Member | 79 | 19-07-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.4499 | +3.50% | 284,674 |
24-03-27 | 0.4347 | -9.21% | 656,232 |
24-03-26 | 0.4788 | -52.12% | 1,382,295 |
24-03-25 | 1 | -2.91% | 721,260 |
24-03-22 | 1.03 | 0.00% | 33,231 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-39.21% | 1.69M | |
+9.30% | 46.03B | |
+52.73% | 44.55B | |
+7.15% | 40.8B | |
-8.78% | 28.25B | |
+18.68% | 27.71B | |
-21.92% | 18.82B | |
+14.62% | 13.91B | |
+31.85% | 12.43B | |
+4.47% | 10.81B |